Loading...

ClearSight Health:

SPOTLIGHT

  • Tue, Oct 11, 2022

    3 minutes read

    A bright future for risk reduction in TAVR procedures using CEP devices

    A hot topic of discussion at recent conferences has been the release of data from the Protected TAVR trial, which looked at Cerebral Embolic Protection (CEP) for Transcatheter Aortic Valve Replacement (TAVR).

    Read More
  • Thu, Mar 04, 2021

    Has COVID-19 pushed medical device sales reps out of the O.R. for good?

  • Thu, Jun 16, 2022

    ClearSight Health at SIR

  • Thu, Jul 14, 2022

    ClearSight Health Employee Spotlight: Rowan Cainer, VP of Growth

  • Thu, Sep 22, 2022

    #TCT2022: Big changes on the horizon for treatment of the “silent killer” that affects nearly half of U.S. adults. Will the U.S. healthcare system be ready?

  • Tue, Oct 11, 2022

    A bright future for risk reduction in TAVR procedures using CEP devices

  • Thu, Mar 04, 2021

    Has COVID-19 pushed medical device sales reps out of the O.R. for good?

  • Thu, Jun 16, 2022

    ClearSight Health at SIR

  • Thu, Jul 14, 2022

    ClearSight Health Employee Spotlight: Rowan Cainer, VP of Growth

  • Thu, Sep 22, 2022

    #TCT2022: Big changes on the horizon for treatment of the “silent killer” that affects nearly half of U.S. adults. Will the U.S. healthcare system be ready?

  • Tue, Oct 11, 2022

    A bright future for risk reduction in TAVR procedures using CEP devices

The Better Way to Grow